Case Type: Mergers & Acquisitions

Duck Creek Technologies, Inc. (NASDAQ: DCT), relating to its proposed sale to Vista Equity Partners. Under the terms of the agreement, DCT shareholders are expected to receive $19.00 in cash per share they own.

Paya Holdings Inc. (NASDAQ: PAYA), relating to its proposed sale to Nuvei Corp. Under the terms of the agreement, PAYA shareholders are expected to receive $9.75 in cash per share they own.

Albireo Pharma, Inc. (NASDAQ: ALBO), relating to its proposed sale to Ipsen. Under the terms of the agreement, ALBO shareholders are expected to receive $42.00 in cash per share they own, plus one Contingent Value Right worth a deferred $10.00 per share.

CinCor Pharma, Inc. (NASDAQ: CINC), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, CINC shareholders are expected to receive $26.00 and one Contingent Value Right worth $10.00 in cash per share they own.

Amryt Pharma Plc (NASDAQ: AMYT), relating to its proposed sale to Chiesi Farmaceutici SpA. Under the terms of the agreement, AMYT shareholders are expected to receive $14.50 plus one Contingent Value Right of up to $2.50 per American Depositary Share they own.

IAA, Inc. (NYSE: IAA), relating to its merger with Ritchie Bros. Auctioneers, Inc. Under the terms of the merger, IAA stockholders will receive $10.00 in cash and 0.5804 shares of Ritchie Bros. common stock per share they own.

Catalyst Biosciences, Inc. (NASDAQ: CBIO), relating to the proposed purchase of F351, a chemical entity owned by GNI Group Ltd.

Horizon Global Corp. (NYSE: HZN), relating to its proposed sale to First Brands Group. Under the terms of the agreement, HZN shareholders are expected to receive $1.75 in cash per share they own.

Maxar Technologies, Inc. (NYSE: MAXR), relating to its proposed sale to Advent International. Under the terms of the agreement, MAXR shareholders are expected to receive $53.00 in cash per share they own.

IsoPlexis Corp. (NASDAQ: ISO), relating to its proposed sale to Berkeley Lights, Inc. Under the terms of the agreement, ISO shareholders are expected to receive 0.612 shares of Berkeley per share they own.